Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.864,97
0,72%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ KALA BIO Inc (KALA) KALA BIO Inc (KALA) Notizie

KALA BIO Inc

KALA
6,30
0,12 (1,94%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/3/202413:00GLOBEKALA BIO Reports Fourth Quarter and Full Year 2023 Financial..
04/3/202413:30EDGAR2Form 8-K - Current report
26/2/202414:00GLOBEKALA BIO to Present at TD Cowen 44th Annual Healthcare..
14/2/202419:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202414:00GLOBEKALA BIO to Present at Oppenheimer 34th Annual Healthcare..
19/1/202422:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/1/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202314:22EDGAR2Form 8-K - Current report
13/11/202314:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:05EDGAR2Form 8-K - Current report
13/11/202314:00GLOBEKALA BIO Reports Third Quarter 2023 Financial Results and..
18/10/202322:04EDGAR2Form SC 13D/A - General statement of acquisition of..
20/9/202322:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/9/202314:00GLOBEKALA BIO to Present at H.C. Wainwright 25th Annual Global..
04/8/202314:00GLOBEKALA BIO Reports Second Quarter 2023 Financial Results and..
02/8/202322:01EDGAR2Form 8-K - Current report
02/8/202322:01GLOBEKALA BIO to Participate in Upcoming Investor Conferences in..
02/8/202314:00GLOBEKala Pharmaceuticals Announces Name Change to KALA BIO
19/7/202322:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..
23/6/202322:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..
02/6/202314:00GLOBEKala Pharmaceuticals to Present at the Jefferies Healthcare..
09/5/202314:00GLOBEKala Pharmaceuticals Reports First Quarter 2023 Financial..
Apertura: 6,32 Min: 6,24 Max: 6,5399
Chiusura: 6,18

La tua Cronologia

NASDAQ
KALA
KALA BIO
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network